Instituto Do Cancer Do Estado De São Paulo

This study tests whether giving the immunotherapy drug pembrolizumab for one year instead of the usual two years is just as effective for people with advanced melanoma that has spread. The trial involves 29 participants in Brazil's public health system. Researchers will track how…

This study tests a gradual dose increase of the drug regorafenib in 28 adults with advanced liver cancer who have already tried other treatments. The goal is to see if starting at a lower dose and slowly raising it helps patients handle the drug better and complete more cycles of…